Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.42 USD | +0.02% | +0.20% | +57.66% |
05-10 | Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-01 | North American Morning Briefing : Traders Wait for -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.66% | 2.2B | |
+4.31% | 111B | |
+11.01% | 105B | |
-11.98% | 22.34B | |
-3.96% | 21.93B | |
-6.03% | 18.59B | |
-36.52% | 18.12B | |
-10.04% | 16.96B | |
+3.26% | 13.7B | |
+37.72% | 12.45B |
- Stock Market
- Equities
- DCPH Stock
- News Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Says FDA Designates Qinlock as Breakthrough Therapy to Treat Gastrointestinal Stromal Tumor